Advanced Cell Technology said on Monday it had won U.S. Food and Drug Administration approval to try out human embryonic stem cells for treating macular degeneration, a common cause of vision loss.
- About
- Projects
- Library
- Bibliography of Bioethics
- Bioethics News
- For Students
- Contacts
- NBNPM
- Advanced Certificate Program
Papildomos nuorodos